(0.01%) 5 214.25 points
(0.02%) 39 033 points
(0.02%) 18 203 points
(-1.33%) $77.34
(0.05%) $2.21
(-0.46%) $2 313.60
(-0.65%) $27.37
(-0.79%) $980.60
(0.19%) $0.931
(0.47%) $10.95
(0.31%) $0.802
(0.21%) $91.63
5 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 10.95%
0.39% $ 15.57
@ $14.92
Wydano: 14 vas. 2024 @ 22:55
Zwrot: 4.36%
Poprzedni sygnał: vas. 14 - 21:11
Poprzedni sygnał:
Zwrot: 1.53 %
Live Chart Being Loaded With Signals
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments...
Stats | |
---|---|
Dzisiejszy wolumen | 547 291 |
Średni wolumen | 955 000 |
Kapitalizacja rynkowa | 1.99B |
EPS | $0 ( 2024-04-30 ) |
Następna data zysków | ( $-0.0300 ) 2024-05-13 |
Last Dividend | $0.400 ( 2020-12-17 ) |
Next Dividend | $0 ( N/A ) |
P/E | -23.59 |
ATR14 | $0.0120 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Stone Warren | Buy | 29 976 | Stock Option (Right to Buy) |
2024-05-02 | Stone Warren | Buy | 17 908 | Restricted Stock Unit |
2024-05-02 | Stone Warren | Buy | 17 908 | Performance Stock Unit |
2024-05-01 | Olivo Alicia C | Sell | 652 | Common Stock |
2024-05-02 | Harris Melody | Buy | 19 984 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
94.65 |
Last 90 transactions |
Buy: 3 508 134 | Sell: 93 304 |
Wolumen Korelacja
Neogenomics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
GNUS | 0.908 |
CNEY | 0.897 |
LMDX | 0.886 |
BROG | 0.871 |
UCL | 0.869 |
CVAC | 0.869 |
CRGE | 0.868 |
LGVN | 0.868 |
BXRX | 0.866 |
PCSA | 0.862 |
10 Najbardziej negatywne korelacje | |
---|---|
PTMN | -0.895 |
IMPP | -0.869 |
APEN | -0.865 |
IMRA | -0.86 |
EYEG | -0.859 |
FRG | -0.85 |
XOMAO | -0.849 |
AGFS | -0.838 |
NESR | -0.832 |
RNLC | -0.829 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Neogenomics Inc Korelacja - Waluta/Towar
Neogenomics Inc Finanse
Annual | 2023 |
Przychody: | $591.64M |
Zysk brutto: | $244.60M (41.34 %) |
EPS: | $-0.700 |
FY | 2023 |
Przychody: | $591.64M |
Zysk brutto: | $244.60M (41.34 %) |
EPS: | $-0.700 |
FY | 2022 |
Przychody: | $509.73M |
Zysk brutto: | $187.90M (36.86 %) |
EPS: | $-1.160 |
FY | 2021 |
Przychody: | $484.33M |
Zysk brutto: | $187.06M (38.62 %) |
EPS: | $-0.0700 |
Financial Reports:
No articles found.
Neogenomics Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.400 | 2020-12-17 |
Last Dividend | $0.400 | 2020-12-17 |
Next Dividend | $0 | N/A |
Payout Date | 2020-12-30 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.400 | -- |
Avg. Dividend % Per Year | 0.09% | -- |
Score | 0.65 | -- |
Div. Sustainability Score | 3.97 | |
Div.Growth Potential Score | 0.0751 | |
Div. Directional Score | 2.02 | -- |
Year | Amount | Yield |
---|---|---|
2020 | $0.400 | 1.38% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.138 | 1.500 | -2.76 | -4.14 | [0 - 0.5] |
returnOnAssetsTTM | -0.0514 | 1.200 | -1.712 | -2.05 | [0 - 0.3] |
returnOnEquityTTM | -0.0894 | 1.500 | -2.10 | -3.16 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 7.48 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.87 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.33 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.331 | -1.500 | 4.48 | -6.72 | [0 - 0.6] |
interestCoverageTTM | 50.47 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.120 | 2.00 | -0.0401 | -0.0802 | [0 - 30] |
freeCashFlowPerShareTTM | -0.314 | 2.00 | -0.157 | -0.314 | [0 - 20] |
debtEquityRatioTTM | 0.588 | -1.500 | 7.65 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.412 | 1.000 | 6.46 | 6.46 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.165 | 1.000 | -5.30 | -5.30 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.0279 | 1.000 | -1.266 | -1.266 | [0.2 - 2] |
assetTurnoverTTM | 0.372 | 0.800 | -0.851 | -0.681 | [0.5 - 2] |
Total Score | 3.97 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -23.31 | 1.000 | -2.46 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0894 | 2.50 | -1.353 | -3.16 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.314 | 2.00 | -0.105 | -0.314 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.120 | 2.00 | -0.0401 | -0.0802 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 2.67 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0249 | 1.000 | -3.12 | 0 | [0.1 - 0.5] |
Total Score | 0.0751 |
Neogenomics Inc
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej